Aug 15, 2018
Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2018 World Congress on Parkinson's Disease and Related Disorders
Jul 31, 2018
Neurocrine Biosciences Reports Second Quarter 2018 Financial Results
Jul 10, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
Jun 08, 2018
Chief Executive Officer of Neurocrine Biosciences, Kevin Gorman, Ph.D., Named EY Entrepreneur Of The Year® 2018 San Diego
May 09, 2018
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference
Apr 23, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2018 Financial Results
Apr 18, 2018
Neurocrine Biosciences to Present New Data from INGREZZA® at the 2018 American Academy of Neurology Annual Meeting
Mar 07, 2018
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
Feb 13, 2018
Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018
Feb 08, 2018
Neurocrine Biosciences to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Feb 06, 2018
Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2017 Financial Results
Jan 07, 2018
Neurocrine Biosciences Announces Retirement of Christopher O'Brien, M.D., and Appointment of Eiry W. Roberts, M.D., as Chief Medical Officer
Jan 07, 2018
Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones
Jan 02, 2018
Neurocrine Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 07, 2017
Neurocrine Biosciences to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
Nov 21, 2017
Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare Conference
Nov 20, 2017
Neurocrine Biosciences Appoints Matt Abernethy as Chief Financial Officer
Nov 08, 2017
Neurocrine Biosciences to Present at the Jefferies 2017 London Healthcare Conference
Oct 31, 2017
Neurocrine Biosciences to Present at the Credit Suisse 26th Annual Healthcare Conference
Oct 24, 2017
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2017 Results